(Q45412862)

English

Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus

scientific article published on 25 July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

swine influenza

1 reference

based on heuristic

inferred from title

author name string

Ronald D Wesley

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kelly M Lager

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Veterinary Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

67-75

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Adenovirus vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

The emergence of novel swine influenza viruses in North America

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Purified influenza virus nucleoprotein protects mice from lethal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2006.07.014

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VETMIC.2006.07.014

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45412862&oldid=2076848974"